Literature DB >> 20217874

Genomic profiling of gastric carcinoma in situ and adenomas by array-based comparative genomic hybridization.

Masahiro Uchida1, Yoshiyuki Tsukamoto, Tomohisa Uchida, Yuta Ishikawa, Takayuki Nagai, Naoki Hijiya, Lam Tung Nguyen, Chisato Nakada, Akiko Kuroda, Tadayoshi Okimoto, Masaaki Kodama, Kazunari Murakami, Tsuyoshi Noguchi, Keiko Matsuura, Masato Tanigawa, Masao Seto, Hisao Ito, Toshio Fujioka, Ichiro Takeuchi, Masatsugu Moriyama.   

Abstract

Although genomic copy number aberrations (CNAs) of gastric carcinoma at the advanced stage have already been extensively characterized by array comparative genomic hybridization (array CGH) analysis, those of gastric carcinoma in situ (CIS) are still poorly understood. Furthermore, no reports have demonstrated correlations between CNAs and histopathological features of gastric adenoma. In this study, we investigated CNAs of 20 gastric CISs (Vienna category 4.2) and 20 adenomas including seven low-grade adenomas (LGA; Vienna category 3) and 13 high-grade adenomas (HGA; Vienna category 4.1), using oligonucleotide-based array CGH. The most frequent aberrations in CIS were gains at 8q (85%) and 20q (50%), and losses at 5q (50%) and 17p (50%), suggesting that these CNAs are involved in the development of CIS. We found that the pattern of CNAs in HGA was quite different from that in LGA. The most frequent CNAs in HGA were gains at 8q (62%) and 7pq (54%), whereas those in LGA were gain at 7q21.3-q22.1 (57%) and loss at 5q (43%). Interestingly, gains at 8q and 7pq, both of which occurred most frequently in HGA, were not detected in any cases of LGA. Of note, 8q gain was detected most frequently in both HGA and CIS but was undetected in LGA. Since HGA is believed to have a higher risk of progression to invasive carcinoma than LGA, these data suggest that 8q gain is important for the malignant transformation of gastric adenoma. Copyright (c) 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20217874     DOI: 10.1002/path.2686

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  16 in total

1.  Genomic profiling of renal cell carcinoma in patients with end-stage renal disease.

Authors:  Toru Inoue; Keiko Matsuura; Taichiro Yoshimoto; Lam Tung Nguyen; Yoshiyuki Tsukamoto; Chisato Nakada; Naoki Hijiya; Takahiro Narimatsu; Takeo Nomura; Fuminori Sato; Yoji Nagashima; Kenji Kashima; Shingo Hatakeyama; Chikara Ohyama; Kazuyuki Numakura; Tomonori Habuchi; Masayuki Nakagawa; Masao Seto; Hiromitsu Mimata; Masatsugu Moriyama
Journal:  Cancer Sci       Date:  2012-01-20       Impact factor: 6.716

2.  Expression of DDX27 contributes to colony-forming ability of gastric cancer cells and correlates with poor prognosis in gastric cancer.

Authors:  Yoshiyuki Tsukamoto; Shoichi Fumoto; Tsuyoshi Noguchi; Kazuyoshi Yanagihara; Yuka Hirashita; Chisato Nakada; Naoki Hijiya; Tomohisa Uchida; Keiko Matsuura; Ryoji Hamanaka; Kazunari Murakami; Masao Seto; Masafumi Inomata; Masatsugu Moriyama
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

3.  Use of autocorrelation scanning in DNA copy number analysis.

Authors:  Liangcai Zhang; Li Zhang
Journal:  Bioinformatics       Date:  2013-09-16       Impact factor: 6.937

4.  Clinical Correlates of Autosomal Chromosomal Abnormalities in an Electronic Medical Record-Linked Genome-Wide Association Study: A Case Series.

Authors:  Hayan Jouni; Khader Shameer; Yan W Asmann; Ribhi Hazin; Mariza de Andrade; Iftikhar J Kullo
Journal:  J Investig Med       Date:  2013-10       Impact factor: 2.895

5.  Differential gene expression profiling of gastric intraepithelial neoplasia and early-stage adenocarcinoma.

Authors:  Xue Xu; Lin Feng; Yu Liu; Wei-Xun Zhou; Ying-Cai Ma; Gui-Jun Fei; Ning An; Yuan Li; Xi Wu; Fang Yao; Shu-Jun Cheng; Xing-Hua Lu
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

6.  Recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer.

Authors:  Xiaohong Wang; Yiqiang Liu; Duanfang Shao; Ziliang Qian; Zhengwei Dong; Yun Sun; Xiaofang Xing; Xiaojing Cheng; Hong Du; Ying Hu; Yingai Li; Lin Li; Bin Dong; Ziyu Li; Aiwen Wu; Xiaojiang Wu; Zhaode Bu; Xianglong Zong; Guanshan Zhu; Qunsheng Ji; Xian-zi Wen; Lian-hai Zhang; Jia-fu Ji
Journal:  Gastric Cancer       Date:  2015-01-25       Impact factor: 7.370

7.  The database of chromosome imbalance regions and genes resided in lung cancer from Asian and Caucasian identified by array-comparative genomic hybridization.

Authors:  Fang-Yi Lo; Jer-Wei Chang; I-Shou Chang; Yann-Jang Chen; Han-Shui Hsu; Shiu-Feng Kathy Huang; Fang-Yu Tsai; Shih Sheng Jiang; Rajani Kanteti; Suvobroto Nandi; Ravi Salgia; Yi-Ching Wang
Journal:  BMC Cancer       Date:  2012-06-12       Impact factor: 4.430

8.  MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region.

Authors:  A-rum Yoon; Ran Gao; Zeenia Kaul; Il-Kyu Choi; Jihoon Ryu; Jane R Noble; Yoshio Kato; Soichiro Saito; Takashi Hirano; Tetsuro Ishii; Roger R Reddel; Chae-Ok Yun; Sunil C Kaul; Renu Wadhwa
Journal:  Nucleic Acids Res       Date:  2011-06-30       Impact factor: 16.971

9.  Genomic profiling of submucosal-invasive gastric cancer by array-based comparative genomic hybridization.

Authors:  Akiko Kuroda; Yoshiyuki Tsukamoto; Lam Tung Nguyen; Tsuyoshi Noguchi; Ichiro Takeuchi; Masahiro Uchida; Tomohisa Uchida; Naoki Hijiya; Chisato Nakada; Tadayoshi Okimoto; Masaaki Kodama; Kazunari Murakami; Keiko Matsuura; Masao Seto; Hisao Ito; Toshio Fujioka; Masatsugu Moriyama
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

10.  Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151.

Authors:  Takeshi Chiyomaru; Soichiro Yamamura; Mohd Saif Zaman; Shahana Majid; Guoren Deng; Varahram Shahryari; Sharanjot Saini; Hiroshi Hirata; Koji Ueno; Inik Chang; Yuichiro Tanaka; Z Laura Tabatabai; Hideki Enokida; Masayuki Nakagawa; Rajvir Dahiya
Journal:  PLoS One       Date:  2012-08-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.